Quest Diagnostics Profit Margin 2010-2025 | DGX

Current and historical gross margin, operating margin and net profit margin for Quest Diagnostics (DGX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Quest Diagnostics net profit margin as of March 31, 2025 is 8.81%.
Quest Diagnostics Annual Profit Margins
Quest Diagnostics Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical MED-OUTP/HM CRE $19.866B $9.872B
Quest Diagnostics, Inc. is the provider of commercial laboratory services. Quest provides lab testing services to physicians, hospitals, managed care organizations, employers, government institutions and other clinical laboratories. The company consists of 2 business groups - Diagnostic Information Services and Diagnostic Solutions. The company's focus is on two elements - to accelerate growth and to drive operational excellence. Restore Growth: The company has adopted seven tactical approaches to accelerate growth such as sales and marketing; development of esoteric testing through a disease focus; partnerships with hospitals and successful testing of international IDNs; creation of value from information assets; leadership in companion diagnostics; extension into adjacent markets. Drive Operational excellence: The company plans to focus on four strategic requirements - to enhance end-to-end customer value chain, enterprise information technology architecture, business performance tools and cost excellence.
Stock Name Country Market Cap PE Ratio
Encompass Health (EHC) US $11.757B 24.92
DaVita (DVA) US $10.848B 14.40
Chemed (CHE) US $8.419B 26.46
Option Care Health (OPCH) US $5.395B 24.05
Elanco Animal Health (ELAN) US $4.840B 10.71
RadNet (RDNT) US $4.004B 84.73
Amedisys (AMED) US $3.151B 21.19
LifeStance Health (LFST) US $2.644B 0.00
Addus HomeCare (ADUS) US $1.932B 22.10
Astrana Health (ASTH) US $1.822B 36.51
U.S Physical Therapy (USPH) US $1.099B 28.03
Aveanna Healthcare Holdings (AVAH) US $0.944B 0.00
Pennant (PNTG) US $0.927B 37.07
Atai Life Sciences (ATAI) DE $0.300B 0.00
Daxor (DXR) US $0.036B 0.00
Ontrak (OTRK) US $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) JP $0.005B 0.00
Psychemedics (PMD) US $0.000B 0.00